FindTrial
Sign In

Study for standardization of lung cancer rehabilitation and modernization of movement treatment of traditional Chinese medicine

Study for standardization of lung cancer rehabilitation and modernization of movement treatment of traditional Chinese medicine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018601
Enrollment
Unknown
Registered
2018-09-29
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

Group 1:lung rehabilitation and Taijiquan
Group 2:conventional therapy

Sponsors

Affiliated Hospital of Nantong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with non-small cell lung cancer (NSCLC) at least six weeks following completion of treatment (surgery, chemotherapy, radiotherapy, immunotherapy); physician/doctor approval; physician rated life expectancy greater than 6 months; informed consent; Eastern Cooperate Oncology Group (ECOG) performance status of 0-2 at study entry and not meeting physical activity/exercise guidelines.

Exclusion criteria

Exclusion criteria: unstable psychiatric/cognitive disorder; comorbidity preventing exercise; ECOG performance status of 3 or 4 at study entry.

Design outcomes

Primary

MeasureTime frame
HRQoL;—

Secondary

MeasureTime frame
Short Physical Performance Battery (SPPB);Functional Exercise Capacity;Muscle strength;symptom;sleep difficulty;Anxiety and Depression;Activity Self–Efficacy;Activity Motivation;—

Countries

China

Contacts

Public ContactJuan Ni

Affiliated Hospital of Nantong University

nijun1000@126.com+86 13057019188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026